These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22320865)

  • 1. Inhibition of mammalian target of rapamycin signaling by CCI-779 (temsirolimus) induces growth inhibition and cell cycle arrest in Cashmere goat fetal fibroblasts (Capra hircus).
    Wang Z; Liu T; Chen Y; Zhang X; Liu M; Fu H; Liu D
    DNA Cell Biol; 2012 Jun; 31(6):1095-9. PubMed ID: 22320865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization and functional analysis of Cashmere goat mammalian target of rapamycin.
    Liang Y; Bao WL; Bao CC; Miao XF; Hao HF; Li SY; Wang ZG; Liu DJ
    DNA Cell Biol; 2012 May; 31(5):839-44. PubMed ID: 22176213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative transcriptomic analysis of the physiological significance of mTOR signaling in goat fetal fibroblasts.
    Fu Y; Zheng X; Jia X; Binderiya U; Wang Y; Bao W; Bao L; Zhao K; Fu Y; Hao H; Wang Z
    BMC Genomics; 2016 Nov; 17(1):879. PubMed ID: 27821074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
    Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing FKBP38 gene by siRNA induces activation of mTOR signaling in goat fetal fibroblasts.
    Fu YT; Zheng X; He Q; Jia XY; Guo ZX; Yao RY; Wang YF; Wang ZG
    Genet Mol Res; 2015 Aug; 14(3):9675-82. PubMed ID: 26345900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells.
    Li S; Liang Y; Wu M; Wang X; Fu H; Chen Y; Wang Z
    Cancer Cell Int; 2013; 13():30. PubMed ID: 23537100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
    Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
    Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML.
    Zeng Z; Sarbassov dos D; Samudio IJ; Yee KW; Munsell MF; Ellen Jackson C; Giles FJ; Sabatini DM; Andreeff M; Konopleva M
    Blood; 2007 Apr; 109(8):3509-12. PubMed ID: 17179228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancer.
    Wang ZG; Fukazawa T; Nishikawa T; Watanabe N; Sakurama K; Motoki T; Hatakeyama S; Omori O; Ohara T; Tanabe S; Fujiwara Y; Takaoka M; Shirakawa Y; Yamatsuji T; Tanaka N; Naomoto Y
    Oncol Rep; 2010 Apr; 23(4):1167-72. PubMed ID: 20204306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akirin2 could promote the proliferation but not the differentiation of duck myoblasts via the activation of the mTOR/p70S6K signaling pathway.
    Sun W; Huang H; Ma S; Gan X; Zhu M; Liu H; Li L; Wang J
    Int J Biochem Cell Biol; 2016 Oct; 79():298-307. PubMed ID: 27590857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
    Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.
    Saqcena M; Patel D; Menon D; Mukhopadhyay S; Foster DA
    Cell Cycle; 2015; 14(14):2285-92. PubMed ID: 25945415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Far-Infrared Irradiation Decreases Proliferation in Basal and PDGF-Stimulated VSMCs Through AMPK-Mediated Inhibition of mTOR/p70S6K Signaling Axis.
    Hwang YJ; Park JH; Cho DH
    J Korean Med Sci; 2023 Oct; 38(41):e335. PubMed ID: 37873631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
    Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
    Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
    Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
    Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin.
    Du W; Gerald D; Perruzzi CA; Rodriguez-Waitkus P; Enayati L; Krishnan B; Edmonds J; Hochman ML; Lev DC; Phung TL
    Lab Invest; 2013 Oct; 93(10):1115-27. PubMed ID: 23938603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
    Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
    Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.